Travere Therapeutics, Inc. ( TVTX) - Key Metrics
TVTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.81 | -$0.37 | $0.62 | $0.86 |
| 2026Q1 | $1.38 | -$0.40 | -$0.44 | -$0.68 |
| 2025Q4 | $1.44 | $0.03 | $0.67 | $0.46 |
| 2025Q3 | $1.85 | $0.29 | $0.16 | $0.16 |
| 2025Q2 | $1.29 | -$0.14 | $0.06 | $0.05 |
TVTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -38.39 |
| 2026Q1 | 0% | -18.57 |
| 2025Q4 | 0% | 318.42 |
| 2025Q3 | 0% | 20.60 |
| 2025Q2 | 0% | -26.43 |
TVTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.51% | 0% |
| 2026Q1 | -2.29% | 0% |
| 2025Q4 | 1.21% | 0% |
| 2025Q3 | 0.66% | 0% |
| 2025Q2 | 0.36% | 0% |
TVTX
Price: $62.14
52 week price:
Earnings Per Share: -0.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 5.7 billion